Join

Compare · ABT vs BCAX

ABT vs BCAX

Side-by-side comparison of Abbott Laboratories (ABT) and Bicara Therapeutics Inc. (BCAX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ABT and BCAX operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
  • ABT is the larger of the two at $157.63B, about 119.4x BCAX ($1.32B).
  • Over the past year, ABT is down 32.2% and BCAX is up 76.4% - BCAX leads by 108.6 points.
  • Both names hit the wire about 6 times in the past 4 weeks.
  • ABT has more recent analyst coverage (25 ratings vs 15 for BCAX).
PerformanceABT-32.20%BCAX+76.36%
2025-06-09+0.00%2026-06-08
MetricABTBCAX
Company
Abbott Laboratories
Bicara Therapeutics Inc.
Price
$90.44-0.69%
$20.11+0.53%
Market cap
$157.63B
$1.32B
1M return
+4.00%
-12.95%
1Y return
-32.20%
+76.36%
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Exchange
NYSE
NASDAQ
IPO
2024
News (4w)
6
6
Recent ratings
25
15
ABT

Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.

Latest ABT

Latest BCAX